Abbott Laboratories (ABT) Cash from Operations Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.99% |
| Dec 31, 2025 | -2.68% |
| Sep 30, 2025 | 6.17% |
| Jun 30, 2025 | 9.14% |
| Mar 31, 2025 | 14.66% |
| Dec 31, 2024 | 3.49% |
| Sep 30, 2024 | 6.79% |
| Jun 30, 2024 | 13.08% |
| Mar 31, 2024 | 7.56% |
| Dec 31, 2023 | 11.47% |
| Sep 30, 2023 | -2.98% |
| Jun 30, 2023 | -0.67% |
| Mar 31, 2023 | 0.62% |
| Dec 31, 2022 | 7.24% |
| Sep 30, 2022 | 6.75% |
| Jun 30, 2022 | 12.27% |
| Mar 31, 2022 | 29.18% |
| Dec 31, 2021 | 21.26% |
| Sep 30, 2021 | 17.29% |
| Jun 30, 2021 | 18.54% |
| Mar 31, 2021 | 97.90% |
| Dec 31, 2020 | 35.61% |
| Sep 30, 2020 | 11.57% |
| Jun 30, 2020 | 7.04% |
| Mar 31, 2020 | 224.08% |
| Dec 31, 2019 | 14.31% |
| Sep 30, 2019 | 10.16% |
| Jun 30, 2019 | 3.33% |
| Mar 31, 2019 | 16.21% |
| Dec 31, 2018 | 1.67% |
| Sep 30, 2018 | 33.13% |
| Jun 30, 2018 | 11.65% |
| Mar 31, 2018 | 19.22% |
| Dec 31, 2017 | 1.76% |
| Sep 30, 2017 | -10.64% |
| Jun 30, 2017 | -8.15% |
| Mar 31, 2017 | -23.74% |
| Dec 31, 2016 | -3.54% |
| Sep 30, 2016 | -16.81% |
| Jun 30, 2016 | -18.34% |
| Mar 31, 2016 | -15.40% |
| Dec 31, 2015 | -18.60% |
| Sep 30, 2015 | -14.06% |
| Jun 30, 2015 | -16.71% |
| Mar 31, 2015 | -73.47% |
| Dec 31, 2014 | -7.55% |
| Sep 30, 2014 | -16.90% |